Cargando…
Association of Paraoxonase-1 and NT-proBNP with Clinical, Clinico-Pathologic and Echocardiographic Variables in Dogs with Mitral Valve Disease
SIMPLE SUMMARY: In order to identify the association of Paraoxonase-1 and N-terminal-prohormone-B-type natriuretic peptide with selected clinico-pathologic and echocardiographic parameters in mitral valve disease, 80 dogs in various clinical stages were enrolled. Paraoxonase-1 concentrations were no...
Autores principales: | Rammal, Diana, Koutinas, Christos K., Athanasiou, Labrini V., Tangalidi, Melpomeni, Rubio, Camila P., Cerón, José J., Tamvakis, Androniki, Patsikas, Michael N., Polizopoulou, Zoe S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866008/ https://www.ncbi.nlm.nih.gov/pubmed/36669034 http://dx.doi.org/10.3390/vetsci10010033 |
Ejemplares similares
-
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010) -
The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008) -
miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)